Vascular Medicine Journal

Overview
Identity
View All

publication venue for

Evaluation of the Venowave (Venous-Return Assist Device) on walking distance in peripheral arterial disease 2013
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD. 29:143-152. 2024
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD. 27:343-349. 2022
The conundrum of resuming anticoagulant therapy after intracerebral bleeding: In whom, when, and how?. 25:60-62. 2020
Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. 24:442-451. 2019
Antithrombotics in stable peripheral artery disease. 24:132-140. 2019
Antithrombotic therapy in aortic diseases: A narrative review. 22:57-65. 2017
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™. 21:506-514. 2016
Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel. 21:400-407. 2016
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study. 21:361-368. 2016
Celiac trunk aneurysm in a patient with Adamantiades-Behçet disease. 19:77-78. 2014
Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. 15:515-516. 2010
Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123–130.. 14:397-399. 2009
Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART). 13:245-253. 2008
Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. 13:263-270. 2008
Oral anticoagulants and non-cardioembolic stroke prevention. 13:55-62. 2008
Applying the gender lens to abdominal aortic aneurysm screening. 12:325-326. 2007
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?. 12:123-127. 2007
Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering. 11:101-109. 2006
The effect of iron status on vascular health. 11:85-91. 2006
Vascular viewpoint. 11:61-63. 2006
Vascular viewpoint. 10:77-78. 2005
Vascular viewpoint. 9:223-224. 2004
Vascular viewpoint. 9:145-146. 2004
The metabolic syndrome: an emerging risk state for cardiovascular disease. 9:55-68. 2004
Vascular viewpoint. 8:289-290. 2003
Vascular viewpoint. 8:147-148. 2003
Vascular viewpoint. 8:63-64. 2003
Vascular viewpoint. 7:337-338. 2002
Vascular viewpoint. 7:249-250. 2002
Vascular viewpoint. 7:157-158. 2002
Vascular viewpoint. 6:269-270. 2001
A systematic review of intra-arterial thrombolytic therapy for lower-limb ischemia.. 6:125-125. 2001
Vascular viewpoint. 6:125-125. 2001
Editorial. 6:1-1. 2001
Vascular viewpoint. 6:61-61. 2001
Vascular viewpoint. 6:61-61. 2001
Therapy of unstable angina with the low molecular weight heparins. 5:217-223. 2000

has subject area

1103 Clinical Sciences (FoR)
Cardiovascular System & Hematology (Science Metrix)